Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine + Modified BUCY for High Risk AML Allo-HSCT
NCT03256071Phase 3Unknown
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Sep 2017
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of decitabine in acute myeloid leukemia (AML), sponsored by First Affiliated Hospital of Soochow University. Status: unknown.
02
Drugs
decitabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT03256071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03256071.